HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Prevacid 24HR Hits Shelves, Targets Rx-Users And Fed-Up Heartburn Sufferers

This article was originally published in The Tan Sheet

Executive Summary

Novartis supports the Nov. 12 launch of over-the-counter proton pump inhibitor Prevacid 24HR with what the firm calls its "largest OTC product launch campaign to date.

You may also be interested in...



After NDA Investment For OTC Switch, Success Swings On More Spending For Advertising

Switch consultant Susan Levy suggests drug firms temper enthusiasm for Rx-to-OTC switches with considering the costs NDAs generate and the histories of switches that haven’t been successes.

Zegerid Ad Focuses On Science As Competitors Seek Emotional Connection

The first television campaign for Zegerid OTC emphasizes the science behind the heartburn drug's unique dual-ingredient formula

Novartis To Launch Nycomed's PPI Pantoloc Control In 14 European Countries

Novartis will launch the OTC proton pump inhibitor Pantoloc Control (pantoprazole 20 mg) in 14 European countries in the second quarter of 2010 under a co-marketing agreement with the product's originator Nycomed

Related Content

Topics

UsernamePublicRestriction

Register

RS135558

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel